UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Surgical Factors Influence Bladder Cancer Outcomes: A Cooperative Group Report

Journal of clinical oncology, 2004-07, Vol.22 (14), p.2781-2789

2004

Volltextzugriff (PDF)

Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy

Cancer, 2007-02, Vol.109 (3), p.536-541

Sarosdy, Michael F.

2007

Volltextzugriff (PDF)

Clinical Evaluation of a Multi-target Fluorescent in Situ Hybridization Assay for Detection of Bladder Cancer

The Journal of urology, 2002-11, Vol.168 (5), p.1950-1954

2002

Volltextzugriff (PDF)

Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer

The Journal of urology, 2015-11, Vol.194 (5), p.1271-1276

2015

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

The New England journal of medicine, 2003-08, Vol.349 (9), p.859-866

2003

Volltextzugriff (PDF)

Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy

Cancer, 2004-08, Vol.101 (4), p.754-760

Sarosdy, Michael F.

2004

Volltextzugriff (PDF)

MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY

The Journal of urology, 2000-04, Vol.163 (4), p.1124-1129

2000

Volltextzugriff (PDF)

Use of a Multitarget Fluorescence In Situ Hybridization Assay to Diagnose Bladder Cancer in Patients With Hematuria

The Journal of urology, 2006-07, Vol.176 (1), p.44-47

2006

Volltextzugriff (PDF)

Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment

The Journal of urology, 1996-08, Vol.156 (2), p.363-367

1996

Volltextzugriff (PDF)

Comparison of goserelin and leuprolide in combined androgen blockade therapy

Urology (Ridgewood, N.J.), 1998-07, Vol.52 (1), p.82-88

1998

Volltextzugriff (PDF)

A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the Bladder

The New England journal of medicine, 1991-10, Vol.325 (17), p.1205-1209

1991

Volltextzugriff (PDF)

Advanced bladder cancer...where are we now and where are we going?

World journal of urology, 2002-08, Vol.20 (3), p.143-143

2002

Volltextzugriff (PDF)

Which is the optimal antiandrogen for use in combined androgen blockade of advanced prostate cancer? The transition from a first-to second-generation antiandrogen

Anti-cancer drugs, 1999-10, Vol.10 (9), p.791-796

Sarosdy, Michael F

1999

Volltextzugriff (PDF)

566: High Disease-Free Survival 5-10 Years after Prostate Brachytherapy Associated with Negative Prostatic Biopsies among Failures

The Journal of urology, 2007-04, Vol.177 (4), p.189-189

Sarosdy, Michael F.

2007

Volltextzugriff (PDF)

A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: A Southwest Oncology Group Study

Urologic oncology, 2005-11, Vol.23 (6), p.386-389

2005

Volltextzugriff (PDF)

1138: Testosterone Replacement after Brachytherapy for Prostate Cancer

The Journal of urology, 2006-04, Vol.175 (4), p.366-366

Sarosdy, Michael F.

2006

Volltextzugriff (PDF)

Long-Term Results of Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer

The Journal of urology, 1989-09, Vol.142 (3), p.719-722

1989

Volltextzugriff (PDF)

The use of the BTA Test in the detection of persistent or recurrent transitional-cell cancer of the bladder

World journal of urology, 1997-04, Vol.15 (2), p.103-106

Sarosdy, M F

1997

Volltextzugriff (PDF)

Author reply

Cancer, 2005-07, Vol.104 (1), p.218-219

Sarosdy, Michael F.

2005

Volltextzugriff (PDF)

Author reply

Cancer, 2005-07, Vol.104 (1), p.218-219

Sarosdy, Michael F.

2005

Volltextzugriff (PDF)

Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study

Urologic oncology, 1995-05, Vol.1 (3), p.119-126

1995

Volltextzugriff (PDF)

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

Journal of clinical oncology, 1992-07, Vol.10 (7), p.1066-1073

1992

Volltextzugriff (PDF)

Prospective clinical trial of a human tumor cloning system

Cancer research (Chicago, Ill.), 1983-04, Vol.43 (4), p.1926-1931

1983

Volltextzugriff (PDF)

Androgen replacement therapy for hypogonadism after brachytherapy for prostate cancer

Brachytherapy, 2006-04, Vol.5 (2), p.106-107

Sarosdy, Michael F.

2006

Volltextzugriff (PDF)

Hypogonadism is more common than expected in men about to undergo prostate brachytherapy, independent of age and degree of erectile dysfunction

Brachytherapy, 2006-04, Vol.5 (2), p.107-107

Sarosdy, Michael F.

2006

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(107)
Reviews
(2)

Sprache

Englisch
(109)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(67)
Science & Technology
(67)
Humans
(59)
Biological And Medical Sciences
(50)
Medical Sciences
(49)
Urology & Nephrology
(47)
Male
(44)
Middle Aged
(29)
Aged
(25)
Pharmacology. Drug Treatments
(23)
Female
(21)
Adult
(18)
Antineoplastic Agents
(16)
Nephrology. Urinary Tract Diseases
(16)
Oncology
(15)
Tumors Of The Urinary System
(15)
Urinary Bladder Neoplasms - Pathology
(14)
Urinary Tract. Prostate Gland
(14)
Aged, 80 And Over
(12)
Immunotherapy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Surgical Factors Influence Bladder Cancer Outcomes: A Cooperative Group Report

Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy

Clinical Evaluation of a Multi-target Fluorescent in Situ Hybridization Assay for Detection of Bladder Cancer

Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer

Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy

MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY

Use of a Multitarget Fluorescence In Situ Hybridization Assay to Diagnose Bladder Cancer in Patients With Hematuria

Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment

Comparison of goserelin and leuprolide in combined androgen blockade therapy

A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the Bladder

Advanced bladder cancer...where are we now and where are we going?

Which is the optimal antiandrogen for use in combined androgen blockade of advanced prostate cancer? The transition from a first-to second-generation antiandrogen

566: High Disease-Free Survival 5-10 Years after Prostate Brachytherapy Associated with Negative Prostatic Biopsies among Failures

A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: A Southwest Oncology Group Study

1138: Testosterone Replacement after Brachytherapy for Prostate Cancer

Long-Term Results of Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer

The use of the BTA Test in the detection of persistent or recurrent transitional-cell cancer of the bladder

Author reply

Author reply

Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

Prospective clinical trial of a human tumor cloning system

Androgen replacement therapy for hypogonadism after brachytherapy for prostate cancer

Hypogonadism is more common than expected in men about to undergo prostate brachytherapy, independent of age and degree of erectile dysfunction

Suchergebnisse filtern